Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year
Patents on the branded versions of Ozempic are due to expire in Canada, China, India and Brazil in 2026. Photograph: Joel Saget / AFP via Getty ImagesDrugmaker Hikma is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents on Novo Nordisk’s blockbuster diabetes and weight loss drugs start expiring as soon as next year.
“It’s not only because of the weight loss ... It is because the weight causes a lot of other diseases,” he said. “So when you treat this, indirectly, you’re treating a lot of diseases. So that’s why it has been a big craze and a lot of people are jumping on it.”‘The Portuguese are very like the Irish in many ways’: the Tipperary man in charge of Denis O’Brien’s luxury Algarve resortAnalysts have estimated the size of the weight loss drug market as anywhere between $80 billion and $140 billion .
Novo Nordisk said patent expiry was a “natural part of the pharmaceutical product lifestyle” and the company was “exploring new molecules, combinations and formulations of treatments, both organically and through external opportunities”.Hikma was founded in Jordan and is the second largest drugmaker in the Middle East and North Africa by sales, after French pharmaceutical company Sanofi.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump Targets Irish Pharma Exports with TariffsPresident Trump's trade war escalates as he threatens tariffs on pharmaceutical imports from Ireland, aiming to reduce the US trade deficit. The move could significantly impact Ireland's economy, which relies heavily on exports to the US.
Read more »
Profits slide at Chanelle PharmaNew private equity owners earn €33m dividend
Read more »
Ireland's Rising Trade Deficit with the US: A Focus on Pharma and TechIreland's trade deficit with the US has significantly increased, making it a focal point in the Trump administration's trade policy. This article explores the reasons behind this widening deficit, highlighting the role of pharmaceutical exports and technology investments.
Read more »
Novo Nordisk to explore how obesity drugs can help patients with addictionDanish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction
Read more »
European shares end week near record highsMarket buoyed by strong gains for Novo Nordisk
Read more »
Five exciting gifts that any mum would want on Mother’s DayMother’s Day gifts can be quite generic, between boxes of chocolates and homemade vouchers sometimes it’s nice to freshen it up and surprise your mum with something new
Read more »